179 related articles for article (PubMed ID: 11449623)
1. [Possibilities of vaccination against HPV infections in cervix carcinoma].
Gissmann L
Zentralbl Gynakol; 2001 May; 123(5):299-301. PubMed ID: 11449623
[TBL] [Abstract][Full Text] [Related]
2. Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine.
Jochmus I; Schäfer K; Faath S; Müller M; Gissmann L
Arch Med Res; 1999; 30(4):269-74. PubMed ID: 10573627
[TBL] [Abstract][Full Text] [Related]
3. Papillomavirus-like particles for serology and vaccine development.
Kirnbauer R
Intervirology; 1996; 39(1-2):54-61. PubMed ID: 8957670
[TBL] [Abstract][Full Text] [Related]
4. Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice.
Revaz V; Benyacoub J; Kast WM; Schiller JT; De Grandi P; Nardelli-Haefliger D
Virology; 2001 Jan; 279(1):354-60. PubMed ID: 11145916
[TBL] [Abstract][Full Text] [Related]
5. [Recombinant therapeutic vaccines against cancer of the uterine cervix].
Berumen J; Villegas N
Salud Publica Mex; 1997; 39(4):288-97. PubMed ID: 9381250
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.
Kaufmann AM; Stern PL; Rankin EM; Sommer H; Nuessler V; Schneider A; Adams M; Onon TS; Bauknecht T; Wagner U; Kroon K; Hickling J; Boswell CM; Stacey SN; Kitchener HC; Gillard J; Wanders J; Roberts JS; Zwierzina H
Clin Cancer Res; 2002 Dec; 8(12):3676-85. PubMed ID: 12473576
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus genotype 16 vaccines for cervical cancer prophylaxis and treatment.
Cornelison TL
Curr Opin Oncol; 2000 Sep; 12(5):466-73. PubMed ID: 10975555
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, properties and applications of papillomavirus-like particles.
Sapp M; Volpers C; Streeck RE
Intervirology; 1996; 39(1-2):49-53. PubMed ID: 8957669
[TBL] [Abstract][Full Text] [Related]
9. [Anti-papillomavirus vaccines and prevention of cervical cancer: progress and prospects].
Hantz S; Alain S; Denis F
Presse Med; 2005 Jun; 34(10):745-53. PubMed ID: 16026130
[TBL] [Abstract][Full Text] [Related]
10. [HPV vaccine in the last trial phase. Is cervix carcinoma soon to be eradicated?].
Grubert TA
MMW Fortschr Med; 2003 Jun; 145(26):34-7. PubMed ID: 12916335
[No Abstract] [Full Text] [Related]
11. [Perspectives for the development of vaccines and immunotherapy against cervico-uterine cancer].
Guzmán-Rojas L; Alcocer-González JM; Madrid-Marina V
Salud Publica Mex; 1998; 40(1):38-46. PubMed ID: 9567657
[TBL] [Abstract][Full Text] [Related]
12. Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.
Daemen T; Pries F; Bungener L; Kraak M; Regts J; Wilschut J
Gene Ther; 2000 Nov; 7(21):1859-66. PubMed ID: 11110419
[TBL] [Abstract][Full Text] [Related]
13. [Biology of the papillomavirus infections: V. Vaccine developments].
Seilles E; Riethmuller D; Mougin C
Ann Biol Clin (Paris); 1999; 57(5):517-24. PubMed ID: 10518053
[TBL] [Abstract][Full Text] [Related]
14. Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers.
Ling M; Kanayama M; Roden R; Wu TC
J Biomed Sci; 2000; 7(5):341-56. PubMed ID: 10971133
[TBL] [Abstract][Full Text] [Related]
15. Preventive vaccines for cervical cancer.
Wheeler CM
Salud Publica Mex; 1997; 39(4):283-7. PubMed ID: 9337561
[TBL] [Abstract][Full Text] [Related]
16. Towards vaccines against human papillomavirus type-16 genital infections.
Cason J; Khan SA; Best JM
Vaccine; 1993; 11(6):603-11. PubMed ID: 8391738
[TBL] [Abstract][Full Text] [Related]
17. Prospects for human papillomavirus vaccine development: emerging HPV vaccines.
Hines JF; Ghim SJ; Jenson AB
Curr Opin Obstet Gynecol; 1998 Feb; 10(1):15-9. PubMed ID: 9484624
[TBL] [Abstract][Full Text] [Related]
18. Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines.
Chen CH; Wang TL; Hung CF; Pardoll DM; Wu TC
Vaccine; 2000 Apr; 18(19):2015-22. PubMed ID: 10706963
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus vaccines.
Stanley MA
Curr Opin Mol Ther; 2002 Feb; 4(1):15-22. PubMed ID: 11883690
[TBL] [Abstract][Full Text] [Related]
20. The use of vaccines in the prevention and treatment of cervical cancer.
Davidson EJ; Kitchener HC; Stern PL
Clin Oncol (R Coll Radiol); 2002 Jun; 14(3):193-200. PubMed ID: 12109821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
